Letter to the editor: FLOUX-PMS study sample considerations
Mult Scler
.
2019 Nov;25(13):1819-1820.
doi: 10.1177/1352458519876025.
Epub 2019 Sep 20.
Authors
Lisa B Grech
1
2
3
,
Ernest Butler
4
,
Stephen Stuckey
5
6
,
Robert Hester
3
Affiliations
1
Department of Health Sciences, Swinburne University, Hawthorn, VIC, Australia.
2
Department of Cancer Experiences Research, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
3
Melbourne School of Psychological Sciences, University of Melbourne, Parkville, VIC, Australia.
4
Department of Neurology, Monash Health, Clayton, VIC, Australia.
5
Department of Imaging, Monash Health, Clayton, VIC, Australia.
6
Department of Imaging, School of Clinical Sciences, Monash Health, Monash University, Clayton, VIC, Australia.
PMID:
31538537
DOI:
10.1177/1352458519876025
No abstract available
Publication types
Comment
MeSH terms
Demyelinating Diseases*
Fluoxetine
Humans
Multiple Sclerosis*
Substances
Fluoxetine